Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

NCT01208766

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • AU-Brisbane-PAH Brisbane, Australia
  • AU-Canberra-CANBERRAHOSPITAL Canberra, Australia
  • AU-Melbourne-ALFRED Melbourne, Australia
  • AU-Sydney-CONCORD Sydney, Australia
View all 208 locations
View Trial Details
Completed

Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)

NCT03904134

Conditions
Acquired Aplastic Anemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +28 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, San Diego Medical Center La Jolla, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford Hospitals and Clinics Stanford, California, United States
View all 52 locations
View Trial Details
Completed

Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma

NCT04022980

Conditions
Brain and Nervous System, Eye and Orbit, Hemic and Lymphatic Diseases, +11 more
Locations
  • Dana Farber Cancer Institute Brookline, Massachusetts, United States
  • UNC Hospitals, The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • The University of Texas - MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions